Cost watchdogs scold J&J for 'overpricing' its new ketamine-like antidepressant - FiercePharma

Submitted by Anonymous (not verified) on Fri, 05/10/2019 - 15:05

Cost watchdogs scold J&J for 'overpricing' its new ketamine-like antidepressant  FiercePharmaJohnson & Johnson's brand-new depression spray Spravato already faces a few challenges. It's restricted to use in a doctor's office, for one, and its efficacy data ...